Alexion Pharmaceuticals, Inc. (ALXN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN)

ALXN 182.50

0.0%

Jul 28 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (399)	12/20/2003 1:06:25 AM
From: aknahow	Read Replies (1) of 824

Perhaps sort of picky, but it is clear that Xoma has the choice after seeing Phase II results. If it does not like what it sees it lets the "drug" go back to MLNM and if MLNM brings it to market it gets a royalty. But it is Xoma saying it does not choose to participate in further trials. Of course MLNM may not go further either in which case there will be no royalty payments.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next